Candida Infections in Children Treated with Conventional Chemotherapy for Solid Tumors (Transplant Recipients Excluded): The Institut Gustave Roussy Pediatrics Department Experience

Pediatric Blood and Cancer

Volumn 42, Issue 4, 2004, Pages 332-337

  Ridola, V ^a   Chachaty, E ^a   Raimondo, G ^a   Corradini, N ^a   Brugieres, L ^a   Valteau Couanet, D ^a   Hartmann, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Candidemia; Children; Tumors

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CORTICOSTEROID; COTRIMOXAZOLE; FLUCYTOSINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CANDIDA ALBICANS; CANDIDIASIS; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ERADICATION THERAPY; FEMALE; GRANULOCYTOPENIA; HUMAN; INCIDENCE; INFANT; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; MYCOSIS; NEUTROPENIA; OUTCOMES RESEARCH; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEPTICEMIA; SOLID TUMOR;

ADOLESCENT; AMPHOTERICIN B; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 1542327728     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10452     Document Type: Review

References (38)

1. Hersh EM, Oppenheim JJ. Impaired lymphocyte transformation in Hodgkin's disease. N Engl J Med 1965;273:1006-1012.
2. Anaissie E, et al. Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review. Clin Infect Dis 1992;14(Suppl 1):S43-S53.
3. Lecciones JA, Lee JW, Navarro EE. Vascular catheter associated fungemia in patients with cancer: Analysis of 155 episodes. Clin Infect Dis 1992;14:875-883.
4. Richet AM, Andremont A, Tancrede C, et al. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991;13:211-215.
5. Gustafson TL, et al. Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy. J Infect Dis 1983;148:230-238.
6. MacDonald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1998;26:642-645.
7. Pfaller MA. Epidemiology of candidiasis. J Hosp Infect 1995;30(Suppl 1):329-338.
8. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immmunocompromised host: Changing patterns, antigenemia, high mortality. Am J Med 1981;71:363-370.
9. Young RC, Bennett JE, Geelhoed CW, et al. Fungemia with compromised host resistance. Ann Intern Med 1974;80:605-612.
10. Besnard M, Hartmann O, Valteau-Couanet D, et al. Systemic Candida infection in pediatric BM autotransplantation: Clinical signs, outcome, and prognosis. Bone Marrow Transplant 1993;11:465-470.
11. Beck-Sagere C, Jarvis WR. Secular trends in the epidemiology of nososcomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993;167:1247-1251.
12. Horn R, Wong B, Kiehn TE, et al. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-655.
13. Marina NM, Flynn PM, Rivera GK, et al. Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer 1991;68:594-599.
14. Gozdasoglu S, Ertem M, Aysev D. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy. Med Pediatr Oncol 1999;32:344-348.
15. Kumar A, Gera R, Kulkarni R. Polyfungal systemic infections in pediatric oncology patients. Am J Pediatr Hematol Oncol 1990;12:331-335.
16. Wiley JM, Smith N, Leventhal BG. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: A multivariate analysis of risk factors. J Clin Oncol 1990;8:280-286.
17. Schwartz RS, Mackintosh FR, Schrier SL, et al. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984;53:411-419.
18. Maksymiuk AW, Thongprasert S, Hopfer R. Systemic candidiasis in cancer patients. Am J Med 1984;30:20-27.
19. Mc Donald L, Baker C, Chenoweth C. Risk factors for candidemia in a Children's Hospital. Clin Infect Dis 1998;26:642-645.
20. Viscoli C, et al. Candidemia in cancer patients: A prospective, multicenter surveillance study by the invasive fungal infection group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999;28:1071-1079.
21. De Gregorio MW, Lee WM, Linker CA, et al. Fungal infections in patients with acute leukemia. Am J Med 1982;73:543-548.
22. Anaissie EJ, Rex JH, Uzun O, et al. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 1998;104:238-245.
23. Cech P, Lehrer RI. Heterogeneity of human neutrophil phagolysosomes: Functional consequences for candidacidal activity. Blood 1984;64:147-151.
24. Bodey GP, Anaissie EJ, Edwards JE. Definitions of Candida infections. In: Bodey GP, editor. Candidiasis: Pathogenesis, diagnosis, and treatment. New York: Raven Press; 1993. pp 407-408.
25. Wey SB, Mori M, Pfaller MA. Risk factors for hospital acquired candidemia. A matched case-control study. Arch Intern Med 1989;149:2349-2353.
26. Lowder JN, Lazarus HM, Herzig RH. Bacteremias and fungemias in oncologic patients with central venous catheters. Changing spectrum of infection. Arch Intern Med 1982;142:1456-1459.
27. Wienber ES, Mc Guire P, Stolar CJH, et al. The CCSG prospective study of venous access devices: An analysis of insertion and causes for removal. J Pediatr Surg 1992;27:155.
28. Dato VM, Dajani AS. Candidemia in children with central venous catheters: Role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990;9:309-314.
29. Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989;8:99-104.
30. Stamos JK, Rowley AH. Candidemia in pediatric population. Clin Infect Dis 1995;20:571-575.
31. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 2002;34:591-599.
32. Nucci M, Colombo AL, Silveira F, et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 1998;19:846-850.
33. Nucci M, Silveira MI, Spector N, et al. Risk factors for death among cancer patients with fungemia. Clin Infect Dis 1998;27:107-111.
34. Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000;19:602-607.
35. Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 1995;21:994-996.
36. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-1272.
37. Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin Infect Dis 1996;22(Suppl 2):S73-S88.
38. Benhamou E, Hartmann O, Nogues C, et al. Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial. Bone Marrow Transplant 1991;7:127-131.